Clinical Study to Evaluate the Pharmacokinetics, Safety, Tolerability and Pharmacodynamic Effects of a Single and Multiple Oral BAY1101042 Tablet Doses in Healthy Male Subjects

Inclusion Criteria: * The informed consent must be signed before any study specific tests or procedures are done. * Healthy male subject. * Age: 18 to 45 years (inclusive) at the screening. * Body mass index (BMI): above/equal 18 and below/equal 29.9 kg/m2. * Ability to understand and follow study-related instructions. Exclusion Criteria: * Pre-existing diseases for which it can be assumed that the absorption, distribution, metabolism, elimination and effects of the study drugs will not be normal. * Subjects with thyroid disorders as evidenced by assessment of thyroid stimulating hormone (TSH) levels outside the normal reference range at screening. * Regular use of medicines. * Smoking more than 10 cigarettes daily. * Systolic blood pressure below 100 or above 145 mmHg (at screening). * Diastolic blood pressure below 50 or above 90 mmHg (at screening). * Heart rate below 50 or above 90 beats/ min (at screening).